Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
November 2016—Olympus announced that the American Urological Association, together with the Society of Urologic Oncology, included the Olympus Narrow Band Imaging (NBI) technology in its newly released guideline for the diagnosis and treatment of non-muscle invasive bladder cancer.
November 2016—Qiagen launched its Paxgene Blood ccfDNA Tube for venous whole blood collection and room temperature stabilization of in vivo circulating cell-free DNA profiles.
November 2016—Horizon Discovery has entered into a co-development and commercialization agreement with Ventana Medical Systems, a member of the Roche group. The agreement covers the development, manufacture, and commercialization of cell-line derivative materials for use as immunohistochemistry reference standards in cancer tissue diagnostics to support the development and validation of IHC assays.
November 2016—MilliporeSigma introduced its Certified Spiking Solution of intact, heavy labeled thyroglobulin in SigMatrix, a synthetic surrogate serum.
November 2016—Siemens Healthineers released a software upgrade for its RapidComm Data Management System version 6.0, an informatics solution to centrally manage in vitro diagnostics analyzers and operators at the point of care. In addition to the system’s enhanced productivity and performance features, RapidComm V6.0 now connects with POC cardiac devices.
November 2016—Aalto Bio Reagents, a developer and provider of raw materials to the in vitro diagnostics industry and to research laboratories worldwide, announced the availability of its Tri-Plex suite of proteins and antibodies, which include its Zika Virus primary Envelope and NS1 proteins plus Chikungunya E2 wild type, E1 mutant, and E1 wild type proteins, and a complete set of Dengue virus proteins for serotypes 1–4.
November 2016—nzo Life Sciences introduced its new line of in situ hybridization and immunohistochemistry reagents for use with Enzo’s Highdef chromogens in ISH and IHC applications.
November 2016—Mindray has received 510(k) clearance from the Food and Drug Administration to market and sell the Mindray BC-5390 Auto Hematology Analyzer. The Mindray BC-5390 analyzer is designed to meet the testing needs of mid-volume hematology laboratories while offering features commonly found on large-volume analyzers.
November 2016—Sarstedt offers low protein binding micro tubes in 0.5 mL, 1.5 mL, and 2.0 mL volumes. These tubes are designed to meet the requirements of protein analytics while maximizing protein recovery rates. The micro tubes are manufactured from a proprietary polypropylene with low protein binding properties and do not feature any potentially contaminating surface coating like silicone.
November 2016—Meridian Life Science released a new catalog that provides a detailed overview of the company’s cardiac and metabolic markers for assay development. Meridian’s top-performing cardiac and metabolic markers include Lp-PLA2, CRP, D-dimer, troponin, NT-proBNP, myoglobin, procalcitonin, FABP, PAPP-A, fibrinogen, sCD40L, MPO, NSE, and galectin-3.
